Missling Christopher U

President and CEO, DirectorANAVEX LIFE SCIENCES CORP. (AVXL) · full profile →Form 4 · filed Mar 26, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 24, 2025Tax withholding(F)282K$9.63$2.7M1.5M
Mar 24, 2025Option exercise(M)500K$0.92$460K1.8M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 24, 2025Option exercise(M)500K$00

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001731122-25-000452) within minutes of acceptance. Every field above traces to the original document. Verify it directly: